# Type 2 Diabetes Mellitus: Evaluating the Safety of New Drugs for Improving Glycemic Control Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/type-2-diabetes-mellitus-evaluating-the-safety-of-new-drugs-for-improving-glycemic-control-guidance-for-industry/8cef335d-7cb8-41c1-b77f-95a0dfb9e587

> FDA guidance document: Type 2 Diabetes Mellitus: Evaluating the Safety of New Drugs for Improving Glycemic Control Guidance for Industry. Issue date: March 10, 2020. Get complete insights and analysis.

---

## Details

- Title: Type 2 Diabetes Mellitus: Evaluating the Safety of New Drugs for Improving Glycemic Control Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2020-03-10
- Comment Close Date: 2020-06-08
- Last Changed: 2020-03-10
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2019-N-6084">FDA-2019-N-6084</a>

## Related Documents

- [Clinical Pharmacology Considerations for Peptide Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-peptide-drug-products/1609c8ed-4d50-4235-8a00-9c63176affe8)
- [Dry Eye: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/dry-eye-developing-drugs-for-treatment-guidance-for-industry/c72442af-b5f2-4a62-88b5-4261f9399657)
- [Contact Dermatitis From Topical Drug Products for Cutaneous Application: Human Safety Assessment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/contact-dermatitis-from-topical-drug-products-for-cutaneous-application-human-safety-assessment-guidance-for-industry/56b78fa3-b2a8-4192-8217-17aadeb25cb7)